Oruka Therapeutics (ORKA) EBT Growth (3y) (2013 - 2024)
Oruka Therapeutics (ORKA) EBT Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.22% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.16% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 86.16% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 41.79% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 95.61% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -38.56% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 38.36% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 64.03% |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -55.22% |
| Mar 31, 2024 | -19.50% |
| Dec 31, 2023 | 39.86% |
| Sep 30, 2023 | 3.95% |
| Jun 30, 2023 | -5.17% |
| Mar 31, 2023 | -1.47% |
| Dec 31, 2022 | 1.86% |
| Sep 30, 2022 | -25.97% |
| Jun 30, 2022 | -35.68% |
| Mar 31, 2022 | -23.66% |
| Dec 31, 2021 | -56.21% |
| Sep 30, 2021 | -42.63% |
| Jun 30, 2021 | -31.70% |
| Mar 31, 2021 | -14.51% |
| Dec 31, 2020 | -6.37% |
| Sep 30, 2020 | 23.42% |
| Jun 30, 2020 | 38.38% |
| Mar 31, 2020 | 33.15% |
| Dec 31, 2019 | 33.68% |
| Sep 30, 2019 | 36.78% |